| Mr David A Brentz, CRNA | |
|
859 Winter St, Lucedale, MS 39452-6603 | |
| (601) 947-3161 | |
| (601) 947-9206 |
| Full Name | Mr David A Brentz |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 14 Years |
| Location | 859 Winter St, Lucedale, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033476288 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R889843 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital Of Tampa | Tampa, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sunshine State Anesthesia Partners Llc | 8123434792 | 299 |
News Archive
Cancer stem cells are particularly difficult to eradicate and are at the heart of why it is so hard to more effectively treat cancer patients, as the post-treatment survival of cancer stem cells drives tumour recurrence, the systemic spread of cancer and, ultimately, treatment failure.
A cost-saving change in Medicare launched in the final days of the Trump administration will cut payments to hospitals for some surgical procedures while potentially raising costs and confusion for patients.
Medstrat partners with major orthopedic company and is pleased to announce the successful completion of a Field-Based Digital Templating pilot program.
Sudden unexpected death (SUD) results from a malfunction of the heart and causes a rapid loss of blood flow through the body, leading to death. It is a very rapid process and may have few or no known warning signs. The overall survival rate for out-of-hospital arrest is only 5-10%. SUD is responsible for upwards of 450,000 people in the United States each year, with North Carolina experiencing an average of 32 SUD-related deaths each day.
Atrix Laboratories, Inc. has announced today that the company has signed a limited feasibility agreement with Aventis SA (NYSE: AVE) to begin preliminary research on two proprietary Aventis compounds formulated in Atrix's delivery technology, Atrigel®. The current agreement is specific for these compounds in an undisclosed therapeutic area.
› Verified 7 days ago
| Entity Name | Gulf-to-bay Anesthesiology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720039746 PECOS PAC ID: 5092628156 Enrollment ID: O20031106000250 |
News Archive
Cancer stem cells are particularly difficult to eradicate and are at the heart of why it is so hard to more effectively treat cancer patients, as the post-treatment survival of cancer stem cells drives tumour recurrence, the systemic spread of cancer and, ultimately, treatment failure.
A cost-saving change in Medicare launched in the final days of the Trump administration will cut payments to hospitals for some surgical procedures while potentially raising costs and confusion for patients.
Medstrat partners with major orthopedic company and is pleased to announce the successful completion of a Field-Based Digital Templating pilot program.
Sudden unexpected death (SUD) results from a malfunction of the heart and causes a rapid loss of blood flow through the body, leading to death. It is a very rapid process and may have few or no known warning signs. The overall survival rate for out-of-hospital arrest is only 5-10%. SUD is responsible for upwards of 450,000 people in the United States each year, with North Carolina experiencing an average of 32 SUD-related deaths each day.
Atrix Laboratories, Inc. has announced today that the company has signed a limited feasibility agreement with Aventis SA (NYSE: AVE) to begin preliminary research on two proprietary Aventis compounds formulated in Atrix's delivery technology, Atrigel®. The current agreement is specific for these compounds in an undisclosed therapeutic area.
› Verified 7 days ago
| Entity Name | Sunshine State Anesthesia Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437757127 PECOS PAC ID: 8123434792 Enrollment ID: O20210305000003 |
News Archive
Cancer stem cells are particularly difficult to eradicate and are at the heart of why it is so hard to more effectively treat cancer patients, as the post-treatment survival of cancer stem cells drives tumour recurrence, the systemic spread of cancer and, ultimately, treatment failure.
A cost-saving change in Medicare launched in the final days of the Trump administration will cut payments to hospitals for some surgical procedures while potentially raising costs and confusion for patients.
Medstrat partners with major orthopedic company and is pleased to announce the successful completion of a Field-Based Digital Templating pilot program.
Sudden unexpected death (SUD) results from a malfunction of the heart and causes a rapid loss of blood flow through the body, leading to death. It is a very rapid process and may have few or no known warning signs. The overall survival rate for out-of-hospital arrest is only 5-10%. SUD is responsible for upwards of 450,000 people in the United States each year, with North Carolina experiencing an average of 32 SUD-related deaths each day.
Atrix Laboratories, Inc. has announced today that the company has signed a limited feasibility agreement with Aventis SA (NYSE: AVE) to begin preliminary research on two proprietary Aventis compounds formulated in Atrix's delivery technology, Atrigel®. The current agreement is specific for these compounds in an undisclosed therapeutic area.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr David A Brentz, CRNA Po Box 607, Lucedale, MS 39452-0607 Ph: (601) 947-3161 | Mr David A Brentz, CRNA 859 Winter St, Lucedale, MS 39452-6603 Ph: (601) 947-3161 |
News Archive
Cancer stem cells are particularly difficult to eradicate and are at the heart of why it is so hard to more effectively treat cancer patients, as the post-treatment survival of cancer stem cells drives tumour recurrence, the systemic spread of cancer and, ultimately, treatment failure.
A cost-saving change in Medicare launched in the final days of the Trump administration will cut payments to hospitals for some surgical procedures while potentially raising costs and confusion for patients.
Medstrat partners with major orthopedic company and is pleased to announce the successful completion of a Field-Based Digital Templating pilot program.
Sudden unexpected death (SUD) results from a malfunction of the heart and causes a rapid loss of blood flow through the body, leading to death. It is a very rapid process and may have few or no known warning signs. The overall survival rate for out-of-hospital arrest is only 5-10%. SUD is responsible for upwards of 450,000 people in the United States each year, with North Carolina experiencing an average of 32 SUD-related deaths each day.
Atrix Laboratories, Inc. has announced today that the company has signed a limited feasibility agreement with Aventis SA (NYSE: AVE) to begin preliminary research on two proprietary Aventis compounds formulated in Atrix's delivery technology, Atrigel®. The current agreement is specific for these compounds in an undisclosed therapeutic area.
› Verified 7 days ago
Mr. Rhett Scott, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 859 Winter St, Lucedale, MS 39452 Phone: 601-766-4286 Fax: 601-947-9948 | |
Mr. Derrick K Scott, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 859 Winter St, Lucedale, MS 39452 Phone: 601-947-3161 Fax: 601-947-9948 | |
George A Strickland, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 859 Winter St, Lucedale, MS 39452 Phone: 601-947-3161 Fax: 601-947-9948 |